AC
IMPV

Apex Capital’s Imperva, Inc. IMPV Stock Holding History

Apex Capital’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-533,400
Closed -$15.3M – 66
2014
Q3 		$15.3M Sell
533,400
-45,400
-8% -$1.23M 1.09% 32
2014
Q2 		$15.2M Buy
+578,800
New +$14.9M 0.95% 43

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
ACM
Andor Capital Management Rye Brook, New York $232M AUM 22.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Apex Capital's IMPV Position: Q4 2014 in Review

Apex Capital sold out of Imperva, Inc. (IMPV) in Q4 2014, closing a stake of 533,400 shares — an estimated $15.3M sold.

Apex Capital first reported a position in IMPV in Q2 2014 and held it in 2 quarters. The position peaked at $15.3M in Q3 2014. 137 funds tracked by Wall St. Rank hold IMPV as of Q4 2014.

  • Apex Capital reported no remaining Imperva, Inc. position as of Q4 2014 after selling out during the quarter.
  • Apex Capital sold 533,400 Imperva, Inc. shares in Q4 2014, an estimated $15.3M.
  • Apex Capital first reported a position in Imperva, Inc. in Q2 2014 and held it in 2 quarters.
  • Apex Capital's Imperva, Inc. position peaked at $15.3M in Q3 2014.
  • 137 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2014.

Based on Apex Capital's 13F filing for Q4 2014, filed 5 Feb 2015.